Literature DB >> 3081112

Phenotypes of the heavy chains of immunoglobulins in patients with diabetic microangiopathy: evidence for an immunogenetic predisposition.

C Mijovic, J A Fletcher, A R Bradwell, A H Barnett.   

Abstract

The B3 allotype of the fourth component of complement (C4B3) is associated with microangiopathy. As C4 is important in the humoral immune response phenotypic variation of other inherited components of the response such as the immunoglobulins could also be associated with microangiopathy. Phenotypes of the heavy chains of immunoglobulins (Gm) were compared in 48 insulin dependent diabetics with and 74 without microangiopathic complications. The Gm(zafnbg) phenotype was found significantly more often in insulin dependent diabetics with complications than in those without (16 (33%) out of 48 v 7 (9%) out of 74, respectively, p less than 0.01). Insulin dependent diabetics with both C4B3 and Gm(zafnbg) had an increased risk of complications compared with insulin dependent diabetics with neither or only one factor. Statistical analysis suggested that these two associations were additive, indicating that they increased risk by independent mechanisms. These findings suggest that susceptibility to diabetic microangiopathy is influenced by genes at or in linkage disequilibrium with both the major histocompatibility complex and the Gm loci.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081112      PMCID: PMC1339419          DOI: 10.1136/bmj.292.6518.433

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  10 in total

Review 1.  Relation of diabetic control to development of microvascular complications.

Authors:  G Tchobroutsky
Journal:  Diabetologia       Date:  1978-09       Impact factor: 10.122

Review 2.  Do genetic factors play a role in the pathogenesis of diabetic microangiopathy?

Authors:  J Barbosa; B Saner
Journal:  Diabetologia       Date:  1984-11       Impact factor: 10.122

3.  IgG heavy-chain (Gm) allotypes and immune response to insulin in insulin-requiring diabetes mellitus.

Authors:  Y Nakao; H Matsumoto; T Miyazaki; N Mizuno; N Arima; A Wakisaka; K Okimoto; Y Akazawa; K Tsuji; T Fujita
Journal:  N Engl J Med       Date:  1981-02-12       Impact factor: 91.245

4.  Statement on the nomenclature of human C4 allotypes.

Authors:  G Mauff; C A Alper; Z Awdeh; J R Batchelor; J Bertrams; G Bruun-Petersen; R L Dawkins; P Démant; J Edwards; H Grosse-Wilde; G Hauptmann; P Klouda; L Lamm; E Mollenhauer; C Nerl; B Olaisen; G O'Neill; C Rittner; M H Roos; V Skanes; P Teisberg; L Wells
Journal:  Immunobiology       Date:  1983-03       Impact factor: 3.144

5.  Interactive effect of Gm allotypes and HLA-B locus antigens on the human antibody response to a bacterial antigen.

Authors:  S Whittingham; J D Mathews; M S Schanfield; J V Matthews; B D Tait; P J Morris; I R Mackay
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

6.  Factors governing the human immune response to injected insulin.

Authors:  W G Reeves; D Barr; C A Douglas; K Gelsthorpe; I Hanning; A Skene; L Wells; R M Wilson; R B Tattersall
Journal:  Diabetologia       Date:  1984-04       Impact factor: 10.122

7.  Anti-insulin-antibodies and late diabetic complications.

Authors:  O O Andersen
Journal:  Acta Endocrinol (Copenh)       Date:  1976-10

8.  The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.

Authors:  U Di Mario; L Ventriglia; M Iavicoli; K Guy; D Andreani
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

9.  Relation of gene expression (allotypes) of the fourth component of complement to insulin dependent diabetes and its microangiopathic complications.

Authors:  C Mijovic; J Fletcher; A R Bradwell; T Harvey; A H Barnett
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-06

10.  Genetic and immunologic factors in microvascular disease in type I insulin-dependent diabetes.

Authors:  H J Bodansky; E Wolf; A G Cudworth; B M Dean; L J Nineham; G F Bottazzo; J A Matthews; A B Kurtz; E M Kohner
Journal:  Diabetes       Date:  1982-01       Impact factor: 9.461

  10 in total
  7 in total

1.  Immunoglobulin heavy chain phenotypes and background retinopathy in non-insulin dependent diabetics.

Authors:  R N Baldwin; C Mijovic; J Fletcher; A R Bradwell; A H Barnett; T D Hockaday
Journal:  BMJ       Date:  1988-10-29

2.  Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  D J Pettitt; M F Saad; P H Bennett; R G Nelson; W C Knowler
Journal:  Diabetologia       Date:  1990-07       Impact factor: 10.122

3.  A genetic study of retinopathy in south Indian type 2 (non-insulin-dependent) diabetic patients.

Authors:  K Hawrami; R Mohan; V Mohan; G A Hitman
Journal:  Diabetologia       Date:  1991-06       Impact factor: 10.122

4.  Raised arterial pressure in parents of proteinuric insulin dependent diabetics.

Authors:  G C Viberti; H Keen; M J Wiseman
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-29

5.  Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus.

Authors:  A I Blakemore; A Cox; A M Gonzalez; J K Maskil; M E Hughes; R M Wilson; J D Ward; G W Duff
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

Review 6.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

7.  Genetic risk factors in diabetic retinopathy.

Authors:  L L Stewart; L L Field; S Ross; R G McArthur
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.